Opening book details…
Can I read Increased risk of myelotoxicity in elderly patients with non-Hodgkin lymphoma : The case for routine prophylaxis with colony-stimulating factor beginning in the first cycle of chemotherapy on EtoBox?
Increased risk of myelotoxicity in elderly patients with non-Hodgkin lymphoma : The case for routine prophylaxis with colony-stimulating factor beginning in the first cycle of chemotherapy by Lodovico Balducci; Lazzaro Repetto is a Medicine article available to read on EtoBox.
What is Increased risk of myelotoxicity in elderly patients with non-Hodgkin lymphoma : The case for routine prophylaxis with colony-stimulating factor beginning in the first cycle of chemotherapy about?
Neutropenia is the major dose‐limiting toxicity of myelosuppressive chemotherapy in patients with cancer. Because of the high incidence of neutropenic complications and death in the early cycles of chemotherapy and the potential for improved outcomes, prophylaxis with colony‐stimulating factor beginning in the first cycle should be routinely considered in elderly patients with non‐Hodgkin lymphoma who are treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP‐like chemotherapy regimens.
Who reads Increased risk of myelotoxicity in elderly patients with non-Hodgkin lymphoma : The case for routine prophylaxis with colony-stimulating factor beginning in the first cycle of chemotherapy?
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Lodovico Balducci; Lazzaro Repetto
- Publisher
- John Wiley and Sons; Wiley (John Wiley & Sons); John Wiley & Sons Inc.; Wiley (ISSN 0008-543X)
- Published
- 2003
- Language
- EN
- Field
- Medicine (Health Sciences)